GSK

Latest stories

3h
FOX Business
Apple Iphone Calling Big Pharma: We Can Help You Develop Better Drugs-- short for "Patient Rheumatoid Arthritis Data from the Real World" -- global
Apple Iphone Calling Big Pharma: We Can Help You Develop Better Drugs
FOX Business / Posted 3 hours ago
-- short for "Patient Rheumatoid Arthritis Data from the Real World" -- global healthcare company GlaxoSmithKline(NYSE: GSK)became the first big drug company using Apple's iPhone and its software platform ResearchKit. It's a moment of truth for... Read more
3h
FOX Business
Apple Iphone Calling Big Pharma: We Can Help You Develop Better Drugs-- short for "Patient Rheumatoid Arthritis Data from the Real World" -- global
Apple Iphone Calling Big Pharma: We Can Help You Develop Better Drugs
FOX Business / Posted 3 hours ago
-- short for "Patient Rheumatoid Arthritis Data from the Real World" -- global healthcare company GlaxoSmithKline(NYSE: GSK)became the first big drug company using Apple's iPhone and its software platform ResearchKit. It's a moment of truth for... Read more
6h
FOX Business
3 Bold Bets On The Future Of Biotechnologyarea of biotechnology. The companies they picked: Cempra(NASDAQ: CEMP), Intrexo
3 Bold Bets On The Future Of Biotechnology
FOX Business / Posted 6 hours ago
area of biotechnology. The companies they picked: Cempra(NASDAQ: CEMP), Intrexon(NYSE: XON), and GlaxoSmithKline(NYSE: GSK). Read on to find out why. Next-generation antibiotics Brian Feroldi: Since antibiotics were first discovered roughly... Read more
6h
FOX Business
3 Bold Bets On The Future Of Biotechnologyarea of biotechnology. The companies they picked: Cempra(NASDAQ: CEMP), Intrexo
3 Bold Bets On The Future Of Biotechnology
FOX Business / Posted 6 hours ago
area of biotechnology. The companies they picked: Cempra(NASDAQ: CEMP), Intrexon(NYSE: XON), and GlaxoSmithKline(NYSE: GSK). Read on to find out why. Next-generation antibioticsMore From Fool.com Brian Feroldi: Since antibiotics were first... Read more
3d
FOX News
Hard To Swallow: Emerging Markets Get Tougher For Drugmakersof China, saying after being appointed to the top job this week that she was "v
Hard To Swallow: Emerging Markets Get Tougher For Drugmakers
FOX News / Posted 3 days ago
of China, saying after being appointed to the top job this week that she was "very excited about what we can do with GSK there". NOT PRETTY But the short-term picture is not pretty. Emerging market growth is the slowest since drug companies... Read more
2 related stories
3d
FOX Business
The Pros And Cons Of Buying Gilead Sciences Stockand others are attempting to knock it off its perch. ViiV Healthcare is a join
The Pros And Cons Of Buying Gilead Sciences Stock
FOX Business / Posted 3 days ago
and others are attempting to knock it off its perch. ViiV Healthcare is a joint venture between GlaxoSmithKline (NYSE: GSK),Pfizer, and Shionogi that competes against Gilead Sciences in HIV, and ViiV's recently launched drugs are enjoying rapid... Read more
3 related stories
3d
FOX Business
The Pros And Cons Of Buying Gilead Sciences Stockand others are attempting to knock it off its perch. ViiV Healthcare is a join
The Pros And Cons Of Buying Gilead Sciences Stock
FOX Business / Posted 3 days ago
and others are attempting to knock it off its perch. ViiV Healthcare is a joint venture between GlaxoSmithKline (NYSE: GSK),Pfizer, and Shionogi that competes against Gilead Sciences in HIV, and ViiV's recently launched drugs are enjoying rapid... Read more
3 related stories
3d
Channel NewsAsia
Hard to swallow: emerging markets get tougher for drugmakersof China, saying after being appointed to the top job this week that she was "v
Hard to swallow: emerging markets get tougher for drugmakers
Channel NewsAsia / Posted 3 days ago
of China, saying after being appointed to the top job this week that she was "very excited about what we can do with GSK there". NOT PRETTY But the short-term picture is not pretty. Emerging market growth is the slowest since drug companies... Read more
2 related stories
3d
Reuters
Hard to swallow: emerging markets get tougher for drugmakersof China, saying after being appointed to the top job this week that she was "v
Hard to swallow: emerging markets get tougher for drugmakers
Reuters / Posted 3 days ago
of China, saying after being appointed to the top job this week that she was "very excited about what we can do with GSK there". NOT PRETTY But the short-term picture is not pretty. Emerging market growth is the slowest since drug companies... Read more
2 related stories
3d
AdWeek
Publicis Communications Hopes These Key Appointments Lead to More New Business Winshelp each of the Publicis agencies win more new business in the coming months,
Publicis Communications Hopes These Key Appointments Lead to More New Business Wins
AdWeek / Posted 3 days ago
help each of the Publicis agencies win more new business in the coming months, adding to such recent wins as P&G Dish Care, GSK, Walmart and Hewlett Packard Enterprise. Carla Serrano and Bill Kanarick have been appointed as co-chief strategy... Read more
3d
Investors Chronicle
New GSK chief - what will be expected of Emma Walmsley? GlaxoSmithKline (GSK) has named its current head of consumer healthcare, Emma
New GSK chief - what will be expected of Emma Walmsley?
Investors Chronicle / Posted 3 days ago
GlaxoSmithKline (GSK) has named its current head of consumer healthcare, Emma Walmsley, as its next chief executive, replacing 'GSK lifer' Andrew Witty at the helm of Britain's biggest... Read more
57 related stories
3d
North-West Evening Mail
Masterplan revealed to transform A590 and A595 in south Cumbriamovement and we need to be making a case for improvements to be able to accommo
Masterplan revealed to transform A590 and A595 in south Cumbria
North-West Evening Mail / Posted 3 days ago
movement and we need to be making a case for improvements to be able to accommodate for that. "The developments at BAE, GSK and Siemens are all going to create additional traffic and we need to be ready for that. There are quite significant... Read more
3d
The Economic Times
From yes-man to coach, companies turn to non-executive chairmen to tide over difficult timesshareholder value creation; and leadership and succession planning." Subodh Bh
From yes-man to coach, companies turn to non-executive chairmen to tide over difficult times
The Economic Times / Posted 3 days ago
shareholder value creation; and leadership and succession planning." Subodh Bhargava, non-executive chairman of GSK and Tata Communications, says a non-executive chair does not have to oversee operations but has to have a good... Read more
4d
Scotsman
RBS | Dundee Uni | Supermarketstreat diseases like cancer and Parkinson’s. The £7.2 million funding from indus
RBS | Dundee Uni | Supermarkets
Scotsman / Posted 4 days ago
treat diseases like cancer and Parkinson’s. The £7.2 million funding from industry to academia comes from GlaxoSmithKline (GSK), Boehringer Ingelheim, and Merck, and secures 38 posts at Dundee for the next four years. The “big four” supermarkets... Read more
14 related stories
4d
Scotsman
Drugs giant GSK names Emma Walmsley as new chief Emma Walmsley joins a small band of female chief executives. Picture: Contribu
Drugs giant GSK names Emma Walmsley as new chief
Scotsman / Posted 4 days ago
Emma Walmsley joins a small band of female chief executives. Picture: Contributed GlaxoSmith­Kline (GSK) has named its consumer healthcare boss Emma Walmsley as chief executive‑designate to replace... Read more
4d
Scotsman
Extra funds for Dundee University to develop new drugstreat diseases like cancer and Parkinson’s. The £7.2 million funding from indu
Extra funds for Dundee University to develop new drugs
Scotsman / Posted 4 days ago
treat diseases like cancer and Parkinson’s. The £7.2 million funding from industry to academia comes from GlaxoSmithKline (GSK), Boehringer Ingelheim, and Merck, and secures 38 posts at Dundee for the next four years. The university said the sum... Read more
4d
TheBull
Glaxo becomes seventh female-led FTSE 100 firmwill become the seventh female chief executive of a group currently listed on L
Glaxo becomes seventh female-led FTSE 100 firm
TheBull / Posted 4 days ago
will become the seventh female chief executive of a group currently listed on London's benchmark shares index. However, GSK's share price finished on a flat note, with analysts noting that some shareholders had wanted an outsider to oversee a... Read more
57 related stories
4d
Times of Malta
GlaxoSmithKline names insider Emma Walmsley as its new CEOboss Abbas Hussain and manufacturing head Roger Connor. Her appointment is lik
GlaxoSmithKline names insider Emma Walmsley as its new CEO
Times of Malta / Posted 4 days ago
boss Abbas Hussain and manufacturing head Roger Connor. Her appointment is likely to be seen as a signal that GSK will retain the consumer business as a core part of its operations, rather than splitting up the company. “Choosing Emma... Read more
10 related stories
5d
Fortune
When Moonshots Fall Back to Earthresearch into real businesses. In January, Verily, Alphabet’s life-sciences moo
When Moonshots Fall Back to Earth
Fortune / Posted 5 days ago
research into real businesses. In January, Verily, Alphabet’s life-sciences moonshot, partnered with GlaxoSmithKline gsk, while its Calico “life-extension” project allied with AbbVieabbv. For more on Google, watch this Fortune... Read more
5d
Channel NewsAsia
Equities in waiting mode ahead of bank decisionsshares dipped less than 0.1 per cent to £16.45, as investors were unimpressed w
Equities in waiting mode ahead of bank decisions
Channel NewsAsia / Posted 5 days ago
shares dipped less than 0.1 per cent to £16.45, as investors were unimpressed with a new boss at the British drugs giant. GSK said it had appointed Emma Walmsley, its head of consumer healthcare, to lead the group and find new treatments in a... Read more
30 related stories
5d
Calcutta News
Drugmaker GlaxoSmithKline decides on Emma Walmsley to replace CEO Andrew Witty in 2017end of March 2017, Walmsley, who currently heads the company’s consumer healthc
Drugmaker GlaxoSmithKline decides on Emma Walmsley to replace CEO Andrew Witty in 2017
Calcutta News / Posted 5 days ago
end of March 2017, Walmsley, who currently heads the company’s consumer healthcare division, will step into his shoes as GSK emerges from a low and scandal-ridden period. Making the announcement at the company’s London headquarters, GSK Chair... Read more
10 related stories
5d
Fortune
GlaxoSmithKline’s Emma Walmsley Just Became Britain’s Most Powerful Businesswomanthat Walmsley, 47, will take over for Andrew Witty, who previously said he woul
GlaxoSmithKline’s Emma Walmsley Just Became Britain’s Most Powerful Businesswoman
Fortune / Posted 5 days ago
that Walmsley, 47, will take over for Andrew Witty, who previously said he would retire in March 2017. Walmsley, who joined GSK in 2010 after 17 years at L’Oreal, will join the board in January. But at some $104 billion, GSK has a market... Read more
5d
Business Standard India
Cipla, Wockhardt join global initiative on tackling drug resistant infectionsthe companies said in a joint statement today. Other companies participating i
Cipla, Wockhardt join global initiative on tackling drug resistant infections
Business Standard India / Posted 5 days ago
the companies said in a joint statement today. Other companies participating in the initiative include Allergan, AstraZeneca, DSM Sinochem Pharmaceuticals, Roche, GSK Pharma, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi... Read more
32 related stories
5d
International Business Times
GlaxoSmithKline's new boss: Who is Emma Walmsley?Walmsley has become the most powerful female chief executive in the UK. When sh
GlaxoSmithKline's new boss: Who is Emma Walmsley?
International Business Times / Posted 5 days ago
Walmsley has become the most powerful female chief executive in the UK. When she takes over at drugs giant GlaxoSmithKline (GSK) from Sir Andrew Witty next April, she will head the largest firm of the seven women running FTSE 100 firms. There are... Read more
57 related stories
5d
heraldscotland
Emma Walmsley set to be FTSE-100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE-100's most powerful woman as Glaxo chief executive
heraldscotland / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
BBC News
GlaxoSmithKline names Emma Walmsley as chief executiveWalmsley will become one of the most powerful business figures in the UK when s
GlaxoSmithKline names Emma Walmsley as chief executive
BBC News / Posted 5 days ago
Walmsley will become one of the most powerful business figures in the UK when she takes over as chief executive of GSK in March of next year. The pharmaceutical giant is the fourth most valuable public company in Britain with 100,000... Read more
57 related stories
5d
News-Medical-Net
Mice study finds new antiviral that can control flu infectionthe influenza A virus. They worked with colleagues from Aarhus University in De
Mice study finds new antiviral that can control flu infection
News-Medical-Net / Posted 5 days ago
the influenza A virus. They worked with colleagues from Aarhus University in Denmark and the respiratory therapy team at GSK in the UK and the results were recently published in EMBO Molecular Medicine. There are between three and five million... Read more
5d
News-Medical-Net
Scientists begin research work at new £650 million Francis Crick Institute buildingfor patients in the clinic - will be a focus for the Crick. For example, the in
Scientists begin research work at new £650 million Francis Crick Institute building
News-Medical-Net / Posted 5 days ago
for patients in the clinic - will be a focus for the Crick. For example, the institute has an ongoing partnership with GSK in which teams of scientists from both organisations work side by side in the lab and benefit from the sharing of ideas... Read more
5d
North-West Evening Mail
GSK announces new chief executiveAndrew Witty. Sir Andrew is retiring this coming March and will be succeeded b
GSK announces new chief executive
North-West Evening Mail / Posted 5 days ago
Andrew Witty. Sir Andrew is retiring this coming March and will be succeeded by Emma Walmsley, who has previously helmed GSK’s £6 billion consumer healthcare division. When Ms Walmsley taken on her new role at the £80 billion company, she will... Read more
57 related stories
5d
Gazette
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Gazette / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
guardian-series
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
guardian-series / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Greenock Telegraph
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Greenock Telegraph / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Harrow Times
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Harrow Times / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
This is West Country
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
This is West Country / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Gazette News
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Gazette News / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Bolton News
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Bolton News / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Belfast Telegraph
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Belfast Telegraph / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
St Albans & Harpenden Review
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
St Albans & Harpenden Review / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Wandsworth Guardian
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Wandsworth Guardian / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
EveningTimes Online
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
EveningTimes Online / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Croydon Guardian
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Croydon Guardian / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Hampshire Chronicle
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Hampshire Chronicle / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
This is Oxfordshire
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
This is Oxfordshire / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Lancashire Telegraph
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Lancashire Telegraph / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
The News and Star
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
The News and Star / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Northern Echo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Northern Echo / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
West Moreland Gazette
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
West Moreland Gazette / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Kingston Guardian
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Kingston Guardian / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Oxford Mail
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Oxford Mail / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
5d
Bury Times
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveat CMC Markets, said: "Some more vocal shareholders had wanted an outsider appo
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Bury Times / Posted 5 days ago
at CMC Markets, said: "Some more vocal shareholders had wanted an outsider appointed to help push through a change in GSK's structure, and are selling shares in a show of disappointment." Ms Walmsley has headed Glaxo's £6 billion consumer... Read more
57 related stories
More

People in this news